| IVKIX | RMFEX | IVKIX / RMFEX | |
| Total Expense Ratio | 0.72 | 0.62 | 116% |
| Annual Report Gross Expense Ratio | 0.90 | 0.62 | 145% |
| Fund Existence | 24 years | 24 years | - |
| Gain YTD | 2.116 | 8.776 | 24% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 232M | 117B | 0% |
| Annual Yield % from dividends | 1.17 | 1.41 | 83% |
| Returns for 1 year | 7.35 | 5.11 | 144% |
| Returns for 3 years | 17.08 | 36.71 | 47% |
| Returns for 5 years | 17.22 | 37.76 | 46% |
| Returns for 10 years | 64.82 | 102.44 | 63% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TTEQ | 42.13 | 0.49 | +1.16% |
| T. Rowe Price Technology ETF | |||
| SNAV | 38.72 | 0.31 | +0.81% |
| Mohr Sector Nav ETF | |||
| SCHY | 32.66 | 0.09 | +0.28% |
| Schwab International Dividend Equity ETF | |||
| EXEQ | 27.52 | N/A | N/A |
| Wedbush ReturnOnLdrsp(R)U.S.Large-CapETF | |||
| LFSC | 45.33 | -0.04 | -0.10% |
| F/m Emerald Life Sciences Innovation ETF | |||